|Application ||WB, E|
|Calculated MW||62229 Da|
|Antigen Region||370-399 aa|
|Other Names||Cleft lip and palate transmembrane protein 1-like protein, CLPTM1-like protein, Cisplatin resistance-related protein 9, CRR9p, CLPTM1L, CRR9|
|Target/Specificity||This CLPTM1L antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 370-399 amino acids from the C-terminal region of human CLPTM1L.|
|Format||Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.|
|Storage||Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.|
|Precautions||CLPTM1L Antibody (C-term) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Enhances cisplatin-mediated apoptosis, when overexpressed.|
|Cellular Location||Membrane; Multi-pass membrane protein|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
CLPTM1L enhances cisplatin-mediated apoptosis, when overexpressed.
Liu, Z., et al. Carcinogenesis 31(11):1977-1981(2010) Hsiung, C.A., et al. PLoS Genet. 6 (8) (2010) : Truong, T., et al. J. Natl. Cancer Inst. 102(13):959-971(2010) Pooley, K.A., et al. Cancer Epidemiol. Biomarkers Prev. 19(7):1862-1865(2010) Turnbull, C., et al. Nat. Genet. 42(7):604-607(2010)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.